Literature DB >> 27747063

Early detection and early treatment of lung cancer: risks and benefits.

Giulia Veronesi1, Pierluigi Novellis1, Emanuele Voulaz1, Marco Alloisio1.   

Abstract

Entities:  

Year:  2016        PMID： 27747063      PMCID： PMC5059339          DOI： 10.21037/jtd.2016.08.76

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  19 in total

1.  Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial.

Authors:  Nanda Horeweg; Carlijn M van der Aalst; Rozemarijn Vliegenthart; Yingru Zhao; Xueqian Xie; Ernst Th Scholten; Willem Mali; Erik Thunnissen; Carla Weenink; Harry J M Groen; Jan-Willem J Lammers; Kristiaan Nackaerts; Joost van Rosmalen; Matthijs Oudkerk; Harry J de Koning
Journal:  Eur Respir J       Date:  2013-07-11       Impact factor: 16.671

2.  Lung cancer risk prediction to select smokers for screening CT--a model based on the Italian COSMOS trial.

Authors:  Patrick Maisonneuve; Vincenzo Bagnardi; Massimo Bellomi; Lorenzo Spaggiari; Giuseppe Pelosi; Cristiano Rampinelli; Raffaella Bertolotti; Nicole Rotmensz; John K Field; Andrea Decensi; Giulia Veronesi
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-02

3.  Positron emission tomography in the diagnostic work-up of screening-detected lung nodules.

Authors:  Giulia Veronesi; Laura L Travaini; Patrick Maisonneuve; Cristiano Rampinelli; Raffaella Bertolotti; Lorenzo Spaggiari; Massimo Bellomi; Giovanni Paganelli
Journal:  Eur Respir J       Date:  2014-09-26       Impact factor: 16.671

4.  Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.

Authors:  Gabriella Sozzi; Mattia Boeri; Marta Rossi; Carla Verri; Paola Suatoni; Francesca Bravi; Luca Roz; Davide Conte; Michela Grassi; Nicola Sverzellati; Alfonso Marchiano; Eva Negri; Carlo La Vecchia; Ugo Pastorino
Journal:  J Clin Oncol       Date:  2014-01-13       Impact factor: 44.544

5.  Diagnostic performance of low-dose computed tomography screening for lung cancer over five years.

Authors:  Giulia Veronesi; Patrick Maisonneuve; Lorenzo Spaggiari; Cristiano Rampinelli; Alessandro Pardolesi; Raffaella Bertolotti; Niccolò Filippi; Massimo Bellomi
Journal:  J Thorac Oncol       Date:  2014-07       Impact factor: 15.609

6.  Clinical characteristics and advantages of primary peripheral micro-sized lung adenocarcinoma over small-sized lung adenocarcinoma.

Authors:  Wang-Yu Zhu; Lin-Lin Tan; Zhao-Yu Wang; Shan-Jun Wang; Li-Yun Xu; Wei Yu; Zhi-Jun Chen; Yong-Kui Zhang
Journal:  Eur J Cardiothorac Surg       Date:  2015-09-15       Impact factor: 4.191

7.  miR-Test: a blood test for lung cancer early detection.

Authors:  Francesca Montani; Matteo Jacopo Marzi; Fabio Dezi; Elisa Dama; Rose Mary Carletti; Giuseppina Bonizzi; Raffaella Bertolotti; Massimo Bellomi; Cristiano Rampinelli; Patrick Maisonneuve; Lorenzo Spaggiari; Giulia Veronesi; Francesco Nicassio; Pier Paolo Di Fiore; Fabrizio Bianchi
Journal:  J Natl Cancer Inst       Date:  2015-03-19       Impact factor: 13.506

8.  International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report.

Authors:  John K Field; Robert A Smith; Denise R Aberle; Matthijs Oudkerk; David R Baldwin; David Yankelevitz; Jesper Holst Pedersen; Scott James Swanson; William D Travis; Ignacio I Wisbuba; Masayuki Noguchi; Jim L Mulshine
Journal:  J Thorac Oncol       Date:  2012-01       Impact factor: 15.609

9.  Maximum standardized uptake value on FDG-PET is a strong predictor of overall and disease-free survival for non-small-cell lung cancer patients after stereotactic body radiotherapy.

Authors:  Atsuya Takeda; Naoko Sanuki; Hirofumi Fujii; Noriko Yokosuka; Shuichi Nishimura; Yousuke Aoki; Yohei Oku; Yukihiko Ozawa; Etsuo Kunieda
Journal:  J Thorac Oncol       Date:  2014-01       Impact factor: 15.609

10.  "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease.

Authors:  Marius Ilie; Véronique Hofman; Elodie Long-Mira; Eric Selva; Jean-Michel Vignaud; Bernard Padovani; Jérôme Mouroux; Charles-Hugo Marquette; Paul Hofman
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.